0000950170-23-027259.txt : 20230609 0000950170-23-027259.hdr.sgml : 20230609 20230609160654 ACCESSION NUMBER: 0000950170-23-027259 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230606 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Other Events FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IDEAYA Biosciences, Inc. CENTRAL INDEX KEY: 0001676725 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474268251 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38915 FILM NUMBER: 231005284 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-443-6209 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Ideaya Biosciences, Inc. DATE OF NAME CHANGE: 20160609 8-K 1 idya-20230606.htm 8-K 8-K
0001676725false00016767252023-06-062023-06-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 6, 2023

IDEAYA Biosciences, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

Delaware

001-38915

47-4268251

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification Number)

7000 Shoreline Court, Suite 350

South San Francisco, California 94080
(Address of principal executive offices, including Zip Code)

 

Registrant’s telephone number, including area code: (650) 443-6209

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class

 

Trading Symbol

 

Name of each exchange on which registered

Common Stock, $0.0001 par value per share

 

IDYA

 

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 7, 2023, IDEAYA Biosciences, Inc. (the “Company”) held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 14, 2023. Only


stockholders of record as of the close of business on April 10, 2023, the record date for the Annual Meeting, were entitled to vote at the Annual Meeting. As of the record date, 48,390,394 shares of the Company’s common stock were outstanding and entitled to vote at the Annual Meeting. The tabulation of the stockholder votes on each proposal brought before the Annual Meeting is as follows:

Proposal 1. The election of three Class I directors to hold office until the 2026 annual meeting of stockholders or until their respective successors are elected:

Nominee

Votes For

Votes Withheld

Broker

Non-Votes

Yujiro S. Hata

41,311,283

1,117,424

2,250,384

M. Garret Hampton, Ph.D.

 

 

36,443,001

 

 

 

5,985,706

 

 

 

2,250,384

 

Catherine J. Mackey, Ph.D.

 

 

40,989,747

 

 

 

1,438,960

 

 

 

2,250,384

 

Proposal 2. The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2023:

Votes For

Votes Against

Abstentions

44,628,878

49,514

999

As a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal.

 

Item 8.01 Other Events.

On June 6, 2023, the Company’s Board of Directors (the “Board”) approved, effective as of June 6, 2023, the amendment of the Company’s Non-Employee Director Compensation Program (the “Program”) to increase (i) the number of shares of the Company’s common stock purchasable, upon vesting, under the Initial Stock Option Grant to new directors from 22,000 shares to 32,400 shares and (ii) the number of shares of the Company’s common stock purchasable, upon vesting, under the Annual Stock Option Grant from 11,000 shares to 16,200 shares. The Board approved the amendment of the Program based on the recommendation of the Compensation Committee of the Board and the compensation market data for the Company’s previously approved peer group of companies, as prepared by Aon Radford, the independent compensation consultant to the Compensation Committee.

The foregoing is only a summary description of the amendment of the Program, does not purpose to be complete and is qualified in its entirety by reference to the amended Program, which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ending June 30, 2023.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

IDEAYA BIOSCIENCES, INC.

Date: June 9, 2023

By: /s/ Yujiro Hata

Yujiro Hata

President and Chief Executive Officer

 

 

|||


EX-101.LAB 2 idya-20230606_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Issuer Tender Offer Entity Address, State or Province Trading Symbol Soliciting Material Entity Address, City or Town Written Communications Entity Central Index Key Entity Tax Identification Number Entity Registrant Name Entity Ex Transition Period Document Period End Date Entity Address, Postal Zip Code Entity Incorporation, State or Country Code Entity Incorporation State Country Code Local Phone Number City Area Code Pre-commencement Tender Offer Cover [Abstract] Security Exchange Name Entity Emerging Growth Company Amendment Flag Securities Act File Number Entity Address, Address Line Two Entity Address, Address Line One Title of 12(b) Security Security 12b Title Document Type EX-101.PRE 3 idya-20230606_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 4 idya-20230606.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information
Jun. 06, 2023
Cover [Abstract]  
Security Exchange Name NASDAQ
Amendment Flag false
Entity Central Index Key 0001676725
Document Type 8-K
Document Period End Date Jun. 06, 2023
Entity Registrant Name IDEAYA Biosciences, Inc.
Entity Incorporation State Country Code DE
Securities Act File Number 001-38915
Entity Tax Identification Number 47-4268251
Entity Address, Address Line One 7000 Shoreline Court
Entity Address, Address Line Two Suite 350
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code (650)
Local Phone Number 443-6209
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.0001 par value per share
Trading Symbol IDYA
Entity Emerging Growth Company true
Entity Ex Transition Period true
XML 6 idya-20230606_htm.xml IDEA: XBRL DOCUMENT 0001676725 2023-06-06 2023-06-06 0001676725 false 8-K 2023-06-06 IDEAYA Biosciences, Inc. DE 001-38915 47-4268251 7000 Shoreline Court Suite 350 South San Francisco CA 94080 (650) 443-6209 false false false false Common Stock, $0.0001 par value per share IDYA NASDAQ true true EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( -N R58'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #;@,E61"'MZ>X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)O)VVEL*';B^))07!!\1:2V=U@TX1DI-VW-XV[740?P&-F_GSS M#4RGO% NX'-P'@,9C#>S'<8HE-^R(Y$7 %$=T0L626I)$A9@X5) M_C0/'5P!"XPPV/A=0+T2<_5/;.X .R?G:-;4-$WEU.1-P5O"[[9U5SP5MQNWA?7'WY78>NTV9M_ M;'P1[#OX=1?]%U!+ P04 " #;@,E6F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M -N R5:IE0J,D 0 . 1 8 >&PO=V]R:W-H965T&UL MC9AMDZHV%,>_2H9V.NW,[@KQ<;?J#*ONK;U/=K6]<]OIBPA1,PN$)D'=;]\3 M<,'>XL$W"D+^_G)R\C\'A@>I7O2.WBD/3L@ MO^,/P0_Z[)C8J:RE?+$G\W#DN):(1SPP5H+!UYY/>!19)>#XYR3JE/]I!YX? MOZD_Y9.'R:R9YA,9?1&AV8V<@4-"OF%99)[EX1=^FE#7Z@4RTODG.13W=ER' M!)DV,CX-!H)8),4W.YX"<3Z 7AA 3P-HSEW\44XY98:-ATH>B+)W@YH]R*>: MCP8XD=A561H%5P6,,^.I##((LB%^$I)98H1Y)?.D6&V(VK!EX$_LK:W@)/A8 M"-(+@K]FR1UQ>S>$NK3]W^$M8"L!:0E(<[WV!;V)W'-%_O+7VBA8PK_KB J% M3KV"S>L'G;* CQQ(7,W5GCOC'[[S>N[/"%^[Y&MCZN,E#S)EHS8[!CN6;#GY MQ&)>1XGK?/*74_\W!*A3 G50(1^6,\R7]"EBVSH0?/R&19HC'-V2HXOJG))I M B2*19!4(3^2]_RUC@A7'I#*'SW,I3W6L\07!-_ #VH8C %;)XS56MG^)BD/RW[<&]AR6_=V;WWC6A M6[$CF8>0@6(C@B)^"" NV>G?=FAO0+L>1ECYO8?:]1NA'X9@UI SIP/R >XC MGY/:56V0[(.#D.5.*FZOV!Q1!F.MO-_#31ME71UD+6M#/-]Q!^CJ5E7$P\T_7TT? MFO'+*+C C[VN^Q.&4A4-#W?[#S* J"QV,D&M#A?I=-JW/>K>8T15C?!P+_\" M#FQX J&)XRPYN9RNI<*%FAHB6M4%VE 79"0"J O)EGR$!%>"1;7M+*[2R%,5 M XH[]T+QVP#"8ZMST1-!ZPC=]N?-IG[]&O0:RF7;[]$U60D3U6Z_!A&;FGGG(H.7&_*]>V<[79(R1?8LRCA)8:IZQQ2* M7-4"BIOW2K'0IM[R-5[+^L3#!>;3KYBGTLKNZ55V/XNYVEJB=Z =07"D;*D M]@&A0="H#(U1Y?;T*K>?'0E$*]$B[XR*)KT6"U>[A-4Z>UZW[SX^,AL'32*^ M 1WWK@^S5<7KA.+$R#1_A%]+8V2<'^XX@YU@;X#K&RG-VXE]*U"^U!G_"U!+ M P04 " #;@,E6GZ ;\+$" #B# #0 'AL+W-T>6QEO%DN7/ZZZ>S;"=I=67=A['- MHN6/O.-%Q[I#)6,>=5 M6R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0G MCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L, M/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(! M6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@ M?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\ M@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T M7!S1JP,Z6PEY7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIU MTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD\%G' M!QR>(W?#$T%^@2O&+(= M/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@ M/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G& MD3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ; 4/2='@//GL? M)=-[*CG_5U/\!%!+ P04 " #;@,E6EXJ[', 3 @ "P %]R96QS M+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0 M"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-# ML%HL/D N&6:WO606IW.D5XA-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H M5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0 ( -N R58ZJJ+G0 $ #P" / M >&PO=V]R:V)O;VLN>&ULC5%=:\,P#/PKQC]@20SH\0RVT+E6J:'3"T4\4V#C-E4DYPH]&09;B(S5 M'WC3B?PT9>H1-N6'$2&%GN5"6&-,W&_T_$8T'D&6A^[ ](2.(2X-PW.D0XMA MU]&(B^S"1I_#6(<0Y_$_,5)=8P5+J@X> @\Y1G"=P) :;)-6P7@H]+BB[H-5 MCX$E)+4* Y7L=D[E],H.KEGD7F08YRB#N+*#\%&MA1H#V#:;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$% @ VX#)5B0>FZ*M M^ $ !H !X;"]?+7_OR4Z?:!1W;J"V\R1& M:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T M==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+) M(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0 ( -N R59ED'F2 M&0$ ,\# 3 6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N M+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78 ME!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')O MJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1< M^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!G MZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%. M6X.^DX K @ $0 M @ &O 9&]C4')O<',O8V]R92YX;6Q02P$"% ,4 " #; M@,E6F5R<(Q & "<)P $P @ ', 0 >&PO=&AE;64O=&AE M;64Q+GAM;%!+ 0(4 Q0 ( -N R5:IE0J,D 0 . 1 8 M " @0T( !X;"]W;W)K&PO&PO7W)E;',O=V]R:V)O M;VLN>&UL+G)E;'-02P$"% ,4 " #;@,E699!YDAD! #/ P $P M @ 'J$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" ( T% ! end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports idya-20230606.htm idya-20230606.xsd idya-20230606_lab.xml idya-20230606_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "idya-20230606.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "idya-20230606.htm" ] }, "labelLink": { "local": [ "idya-20230606_lab.xml" ] }, "presentationLink": { "local": [ "idya-20230606_pre.xml" ] }, "schema": { "local": [ "idya-20230606.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "idya", "nsuri": "http://www.ideayabio.com/20230606", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "idya-20230606.htm", "contextRef": "C_a82d31e2-f30e-4e28-89ee-ec9afe4d3239", "decimals": null, "first": true, "lang": "en-US", "name": "dei:SecurityExchangeName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "idya-20230606.htm", "contextRef": "C_a82d31e2-f30e-4e28-89ee-ec9afe4d3239", "decimals": null, "first": true, "lang": "en-US", "name": "dei:SecurityExchangeName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ideayabio.com/20230606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0000950170-23-027259-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-027259-xbrl.zip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end